Join to View Full Profile
22 S Greene StBaltimore, MD 21201
Phone+1 410-328-8668
Fax+1 410-328-6896
Dr. Zandberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 2009 - 2012
George Washington UniversityResidency, Internal Medicine, 2005 - 2008
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2005
Certifications & Licensure
PA State Medical License 2018 - 2026
MD State Medical License 2012 - 2019
VA State Medical License 2005 - 2010
DC State Medical License 2005 - 2008
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2012 Aug 20
- Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2014 Oct 23
- Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck Start of enrollment: 2016 Mar 09
- Join now to see all
Publications & Presentations
PubMed
- The interdependence of depressive symptoms and sleep in dyads affected by cancer.George N Diamantis, Youngmee Kim, Zoe Ofori-Atta, LaNita Devine, Michael H Antoni
Health Psychology. 2025-04-01 - Amlodipine, an L-type Ca2+ channel inhibitor, regulates release of extracellular vesicles from tumor cells.Sujan K Mondal, Chang-Sook Hong, Jie Han, Brenda Diergaarde, Dan P Zandberg
Carcinogenesis. 2025-03-23 - Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcome.Patricia McCoon, Ying Wang, Zhongwu Lai, Qu Zhang, Weimin Li
Clinical Cancer Research. 2025-03-13
Journal Articles
- Intratumor Genetic Heterogeneity in Squamous Cell Carcinoma of the Oral CavityScott E Strome, John C Papadimitriou, Dan P Zandberg, Head & Neck
Press Mentions
Combination Immunotherapy Before Surgery May Increase Survival in People with Head and Neck CancerMarch 13th, 2025- OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical StudyJanuary 28th, 2021
Hill Day Advocates Present Unified Voice in Support of NIH, NCI FundingMay 1st, 2019- Join now to see all
Grant Support
- Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2027
- Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
